Dublin-based medical technology company Alltracel narrowed losses in 2005 and said the first quarter has started strongly with revenues up 7 per cent at €4.4 million.
For 2005 the company recorded a pretax loss of €2.1 million compared to a loss of €5.4 million on sales of €19.2 million against €4.6 million in 2004.
The company - which specialises in developing natural treatments for wound care, oral care and heart ailments - said the better results were achieved due to a strong performance from the oral care division and strict operating cost control.
Chief executive Tony Richardson said: "2005 has been a strong year for Alltracel with group revenue continuing its significant growth and with profitability now clearly in sight following the achievement of positive trading in the second half of the year."